News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Year: 2016

Epigenomics AG issues new shares by way of private placement

PDF Publication of Inside Information according to Article 17 MAR Epigenomics AG issues new shares by way of private placement Not for distribution in the United States of America Berlin, Germany, November 16, 2016 – Epigenomics AG, Berlin, Germany (Prime Standard Segment, Frankfurt: ECX, ISIN: DE0000A11QW50), announces that the Company is raising EUR 2.1 million of gross […]

Read more

Epigenomics AG to participate in investor conferences

PDF Berlin (Germany) and Germantown, MD (U.S.A.), November 14, 2016 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) today announced that Greg Hamilton, Chief Executive Officer, will participate in the following investor conferences: -Canaccord Genuity Medical Technologies & Diagnostics Forum, Thursday November 17, 2016, New York, Westin New York Grand Central, Presentation: 10:00 am […]

Read more

Epigenomics AG Announces 2016 Third Quarter and Nine Months Financial Results and Reports on Operational Highlights

PDF Revenue increased by 83% in Q3 2016 over same period the prior year Full-year 2016 revenue guidance tightened to EUR 3.5m to EUR 5.0m Epigenomics signs exclusive distribution agreement for Epi proColon in South-East Asia Financial position improved by raising EUR 5.0 million in a private placement to UChip Technology Ltd, a subsidiary of […]

Read more

ARUP Laboratories to Offer Epi proColon®, Epigenomics’ Blood-Based Colorectal Cancer Screening Test

PDF Berlin (Germany) and Germantown, MD (U.S.A.), November 8, 2016 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), announced that ARUP Laboratories (Salt Lake City, Utah) is the next major U.S. laboratory to offer Epi proColon®, the first and only FDA-approved blood-based test for colorectal cancer screening. “I am excited about the inclusion of our […]

Read more

Epigenomics AG issues new shares by way of private placement

PDF Publication of Inside Information according to Article 17 MAR Epigenomics AG issues new shares by way of private placement Not for distribution in the United States of America Berlin, Germany, November 7, 2016 – Epigenomics AG, Berlin, Germany (Frankfurt Prime Standard: ECX, ISIN: DE0000A11QW50), announces that the Company is raising close to EUR 5.0 million of […]

Read more

Epigenomics AG: Journal of the American Medical Association (JAMA) publishes “letter to the editor” that clarifies clinical performance data for Epi proColon®

PDF Berlin (Germany) and Germantown, MD (U.S.A.), October 26, 2016 – The Journal of the American Medical Association (JAMA) published a “letter to the editor” discussing the importance of participation and clarifying clinical performance data for Epi proColon, the first and only FDA-approved blood test for colorectal cancer screening. In June 2016, JAMA had published […]

Read more